Health and wellbeing

Xyla celebrates QISMET accreditation for NDPP and T2DR programmes 

Published 09 January, 2026

Xyla’s delivery of the NHS Diabetes Prevention Programme (NDPP) and Type 2 Diabetes Remission (T2DR) services have been officially accredited by QISMET, the UK’s independent quality assurance body for self-management and structured education programmes. 

For NDPP, this marks another successful renewal, maintaining accreditation we have held for the last eight years. For T2DR, it represents our first accreditation, recognising the programme’s high-quality delivery, strong outcomes and the dedication of our specialist team behind it. 

Why QISMET matters 

QISMET accreditation reflects our commitment to delivering structured education that is safe, effective and grounded in national best practice. It ensures our programmes: 

  • Follow evidence based guidelines, including NICE recommendations 
  • Maintain consistent, high standards across all delivery channels, in person and online 
  • Offer clear learning pathways and measurable outcomes 
  • Empower participants to take control of their health long term 

For commissioners and system partners, QISMET provides confidence that Xyla delivers services with robust governance, proven quality and an ongoing culture of improvement. 

Delivering real change across the country

Thanks to the dedication of our coaches, programme leads and clinical teams, thousands of people across the UK have been supported to reduce their risk of type 2 diabetes or work towards remission. 

NHS Diabetes Prevention Programme 

Xyla is the largest provider of the NHS Diabetes Prevention Programme across the UK. 

We received our 850,000th referral during last year’s Type 2 Diabetes Prevention Week. 

In 2025; 

We supported

21,494 people to reduce their risk of diabetes

98%

would recommend the programme 

96%

improved exercise, diet, and lifestyle habits 

96%

felt more positive after sessions 

Type 2 Diabetes Remission 

Xyla’s Type 2 Diabetes Remission service supports participants with specialised nutrition, psychology and physical activity to support weight loss, foster lasting behavioural changes to promote type 2 diabetes remission. In 2025;  

  • We received 3,563 referrals from GPs across the UK 
  • 97% rated the service good or very good 
  • T2DR has now supported 9,958 people to work towards diabetes remission since launch in 2020. 

Building a healthier future for all 

We work closely with Integrated Care Boards, Primary Care Networks and GP practices to understand local priorities, improve population health outcomes and reduce long-term system pressures. Whether you are looking to enhance prevention, expand capacity or strengthen diabetes pathways, our accredited programmes can be seamlessly integrated into your local model of care. 

Share this article

Contact us

Have any questions about our services? Whether you’re wondering about how we can help your health goals, or assist your healthcare organisation, we’d love to hear from you.

Get in touch

Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)